Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice.
Mukherjee, Siddhartha, Noopur Raje, Jesse A Schoonmaker, Julie C Liu, Teru Hideshima, Marc N Wein, Dallas C Jones, et al. 2008. “Pharmacologic Targeting of a Stem/Progenitor Population in Vivo Is Associated With Enhanced Bone Regeneration in Mice.”. The Journal of Clinical Investigation 118 (2): 491-504.